HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

[(2S,3R,4S,5R)-4,5-Dihydroxy-2-[(2R,3S,4R,5R,6R)-3,4,5-trihydroxy-2-[[(3R,9S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl] acetate

HCID 158692
New noteNew reactionRequest quotes
Print preview
Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
84676-89-1
Standard SMILES
CC(=O)O[C@H]1[C@H](O[C@]2(O)[C@H](O)[C@@H](CO)O[C@@H](O[C@H]3CC4C5(CC[C@]6(C)[C@@H]([C@@]7(C)CC[C@@H](C(C)(C)O)O7)[C@@H](O)C[C@@]46C)C[C@@]54CCCC(C)(C)C34)[C@@H]2O)OC[C@@H](O)[C@@H]1O
InChIKey
LFJNPJBIDAQEHH-BXPIHXSGSA-N
Molecular formula
C43H70O15
Average molar mass
827 g/mol
Monoisotopic mass
826.47147152

Names & identifiers

Preferred name
[(2S,3R,4S,5R)-4,5-Dihydroxy-2-[(2R,3S,4R,5R,6R)-3,4,5-trihydroxy-2-[[(3R,9S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl] acetate
IUPAC
[(2S,3R,4S,5R)-4,5-dihydroxy-2-[(2R,3S,4R,5R,6R)-3,4,5-trihydroxy-2-[[(3R,9S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl] acetate
English name
Astragaloside II
Molecular formula
C43H70O15
Molecular weight
827.02

Names & synonyms

UNII-0K5J34DHEN[(2S,3R,4S,5R)-4,5-Dihydroxy-2-[(2R,3S,4R,5R,6R)-3,4,5-trihydroxy-2-[[(3R,9S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl] acetateAstragaloside BAstragaloside-ⅡAstragaloside ⅡASTRAGALOSIDE IICyclosiversioside DAstragaloside II-RMCyclosieversioside DASTRAGALOSIDE II(SH)Astragaloside II,98%AstrasieversianinVIII

Database identifiers

CAS
84676-89-1
PubChem CID
158692

Properties

Computed structural properties

XLogP
2.6
Topological polar surface area
234 Ų
Hydrogen bond donors
8
Hydrogen bond acceptors
15
Rotatable bonds
9
Heavy atoms
58
Formal charge
0
Complexity
1,590

Physicochemical properties

Melting point
251 · 251~253℃
Boiling point
897.4 · 897.4±65.0 °C(Predicted)
Density
1.37 · 1.37±0.1 g/cm3(Predicted)
storage temp.
2 · 2-8°C(protect from light)
solubility
Methanol (Very Slightly), Pyridine (Slightly)
form
Solid
pka
12.9 · 12.90±0.70(Predicted)
color
White to Off-White
Major Application
food and beverages
InChIKey
AYWNHWGQTMCQIV-PENCHUSISA-N
FDA UNII
0 K5J34DHEN · 0K5J34DHEN
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
WGK Germany
3 · WGK 3
HS Code
29389090 · 29389090
Storage Class
11 · 11 - Combustible Solids

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
WGK 3
hs_code
29389090
Storage Class
11 - Combustible Solids

Chemistry & industry

Applications

UsesAstragaloside II has cardioprotective effects as well as causing improvement in cognitive function. Used in the prevention of cardio-cerebral vascular diseases.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes